(WTW) Willis Towers Watson - Ratings and Ratios
Exchange: NASDAQ • Country: United Kingdom • Currency: USD • Type: Common Stock • ISIN: IE00BDB6Q211
WTW: Insurance Brokerage, Consulting, Risk Management, Investment, Software
Willis Towers Watson Public Limited Company (WTW) is a global leader in advisory, broking, and solutions, operating through two primary segments: Health, Wealth & Career and Risk & Broking. The company provides comprehensive services including strategy and design consulting, plan management, and broking for health and retirement plans. It offers actuarial support, retirement consulting, and integrated solutions such as investment management and pension administration. WTW also addresses total rewards and talent issues with data, software, and products, and provides risk advice and insurance brokerage across various industries. Additionally, WTW offers software, risk management, and business services, positioning itself as a holistic solutions provider in the insurance and consulting sectors.
Founded in 1828 and headquartered in London, WTW rebranded from Willis Group Holdings in 2016. With a market capitalization of $31.97 billion, WTW is a significant player in the multi-line insurance industry. The companys forward P/E of 18.42 indicates growth expectations, while a P/B ratio of 4.03 reflects market valuation of its assets. However, a negative RoE of -1.23 may signal profitability challenges. WTWs diverse service offerings and global reach underscore its role as a key advisor to organizations worldwide.
3-Month Forecast: WTWs stock is currently trading at 321.00, below its SMA20 (326.49) and SMA50 (327.16), suggesting short-term weakness. Support is anticipated at the SMA200 level of 303.47. The ATR of 8.45 indicates moderate volatility, with potential price fluctuations within an 8-point range. While the negative RoE may concern investors, the forward P/E suggests optimism for future earnings. Resistance levels around 326-327 could test the stocks upward momentum, with potential upside if these levels are breached.
Additional Sources for WTW Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
WTW Stock Overview
Market Cap in USD | 30,445m |
Sector | Financial Services |
Industry | Insurance Brokers |
GiC Sub-Industry | Multi-line Insurance |
IPO / Inception | 2016-01-05 |
WTW Stock Ratings
Growth Rating | 69.4 |
Fundamental | 5.25 |
Dividend Rating | 56.5 |
Rel. Strength | -0.77 |
Analysts | 4.11/5 |
Fair Price Momentum | 316.88 USD |
Fair Price DCF | 327.37 USD |
WTW Dividends
Dividend Yield 12m | 1.18% |
Yield on Cost 5y | 2.08% |
Annual Growth 5y | 5.06% |
Payout Consistency | 97.4% |
WTW Growth Ratios
Growth Correlation 3m | -24.3% |
Growth Correlation 12m | 92.2% |
Growth Correlation 5y | 78.7% |
CAGR 5y | 12.29% |
CAGR/Max DD 5y | 0.43 |
Sharpe Ratio 12m | 1.24 |
Alpha | 13.65 |
Beta | 0.438 |
Volatility | 32.83% |
Current Volume | 577k |
Average Volume 20d | 702.1k |
As of May 02, 2025, the stock is trading at USD 306.36 with a total of 576,960 shares traded.
Over the past week, the price has changed by -0.23%, over one month by -9.09%, over three months by -7.10% and over the past year by +21.72%.
Neither. Based on ValueRay Fundamental Analyses, Willis Towers Watson is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 5.25 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WTW as of May 2025 is 316.88. This means that WTW is currently overvalued and has a potential downside of 3.43%.
Willis Towers Watson has received a consensus analysts rating of 4.11. Therefor, it is recommend to buy WTW.
- Strong Buy: 8
- Buy: 5
- Hold: 4
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, WTW Willis Towers Watson will be worth about 346 in May 2026. The stock is currently trading at 306.36. This means that the stock has a potential upside of +12.94%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 366.3 | 19.6% |
Analysts Target Price | 366.2 | 19.5% |
ValueRay Target Price | 346 | 12.9% |